Floatz logo

Therapeutic Asset Ratings

18,139 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Fluorouracilum
Triple-Negative Breast Carcinoma
PfizerP3B (63)
Giredestrant
Breast Cancer
Genentech, Inc.P3B (63)
Hydrocortisone
Childhood Acute Myeloid Leukemia
Children's Oncology GroupP3B (63)
Hydrocortisone
Cirrhosis Of Liver
Elizabeth C. VernaP3B (63)
Hydrocortisone
T-Cell Childhood Acute Lymphocytic Leukemia
National Cancer Institute (NCI)P3B (63)
Hydronidone
Chronic Hepatitis B Virus Infection
Beijing Continent Pharmaceutical Co, Ltd.P3B (63)
Hypoxanthine Riboside
Parkinson Disease
Fujita Health UniversityP3B (63)
Iberdomide
Plasma Cell Myeloma
Dana-Farber Cancer InstituteP3B (63)
Ibrutinib
Lymphoma
Inhye AhnP3B (63)
Ibuprofen
Osteoarthritis, Knee
QC Kinetix LLCP3B (63)
Idarubicin
Lymphoblastic Lymphoma
St. Jude Children's Research HospitalP3B (63)
Idarubicin
Myelodysplastic/Myeloproliferative Neoplasm
Fred Hutchinson Cancer CenterP3B (63)
Irinotecan
Hepatocellular Carcinoma
University of FloridaP3B (63)
Irinotecan
Appendix Carcinoma
City of Hope Medical CenterP3B (63)
Irinotecan
Digestive System Neoplasm
PfizerP3B (63)
Irinotecan
Intestinal Neoplasm
PfizerP3B (63)
Irinotecan
Appendix Adenocarcinoma
City of Hope Medical CenterP3B (63)
Isocyclophosphamide
Childhood Acute Lymphoblastic Leukemia
Martin SchrappeP3B (63)
Isocyclophosphamide
B-Cell Acute Lymphoblastic Leukemia
Children's Oncology GroupP3B (63)
Isocyclophosphamide
Ovarian Cancer
Brigham and Women's HospitalP3B (63)
Isocyclophosphamide
Classic Hodgkin Lymphoma
National Cancer Institute (NCI)P3B (63)
Ivosidenib
Acute Myeloid Leukemia With Multilineage Dysplasia
Institut de Recherches Internationales ServierP3B (63)
Lapatinib
HER2 Positive Breast Carcinoma
Deraya UniversityP3B (63)
Lenalidomide
Lymphoma
Memorial Sloan Kettering Cancer CenterP3B (63)
Lenvatinib
Colorectal Cancer
Seoul National University Bundang HospitalP3B (63)
Showing 2776 to 2800 of 18,139 assets
PreviousPage 112 of 726Next